📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. (2022)

First Author: Anderson GSF

Attributed to: Molecular Mechanisms of Cell Death funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021015161

PubMed Identifier: 35134130

Publication URI: http://europepmc.org/abstract/MED/35134130

Type: Journal Article/Review

Volume: 139

Parent Publication: Blood

Issue: 16

ISSN: 0006-4971